Literature DB >> 8069775

Platelet adhesion, shape change, and aggregation: rapid initiation and signal transduction events.

A R Gear1.   

Abstract

Blood platelets are essential for hemostasis, and knowledge of their function is important for understanding both normal and pathologic situations. A number of approaches have been used to evaluate platelet adhesion, aggregation, and secretion, and within the last 10 years much interest has been directed to the biochemical mechanisms and signal transduction events occurring during these various phases of function. New information has come from development of technologies to evaluate the changes occurring immediately after platelet activation and consistent with the speed needed for hemostasis in the arterial circulation. Use of rapid flow and mixing technologies as seen in quenched-flow, continuous-flow, and stopped-flow devices has revealed that platelet aggregation, shape change, adhesion, and secretion begin within 1 s and may be nearly complete by 5 s. Biochemical changes such as in protein phosphorylation, calcium release, and phospholipid hydrolysis are clearly evident in hundreds of milliseconds. Therefore, it is necessary to understand these early events in signal transduction and to assess alterations that may occur in diseases such as diabetes.

Entities:  

Mesh:

Year:  1994        PMID: 8069775     DOI: 10.1139/y94-044

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  10 in total

1.  Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow.

Authors:  A Bonnefoy; Q Liu; C Legrand; M M Frojmovic
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

2.  Platelet adhesion to collagen activates a phosphoprotein complex of heat-shock proteins and protein phosphatase 1.

Authors:  A R Gear; C G Simon; R Polanowska-Grabowska
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

3.  Grow with the flow: a spatial-temporal model of platelet deposition and blood coagulation under flow.

Authors:  Karin Leiderman; Aaron L Fogelson
Journal:  Math Med Biol       Date:  2010-05-03       Impact factor: 1.854

4.  Geldanamycin disrupts platelet-membrane structure, leading to membrane permeabilization and inhibition of platelet aggregation.

Authors:  S Suttitanamongkol; A R Gear; R Polanowska-Grabowska
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

5.  A Mathematical Model of Venous Thrombosis Initiation.

Authors:  Priscilla Elizondo; Aaron L Fogelson
Journal:  Biophys J       Date:  2016-12-20       Impact factor: 4.033

6.  Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.

Authors:  A L Kuharsky; A L Fogelson
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

7.  Quantification of particle residence time in abdominal aortic aneurysms using magnetic resonance imaging and computational fluid dynamics.

Authors:  Ga-Young Suh; Andrea S Les; Adam S Tenforde; Shawn C Shadden; Ryan L Spilker; Janice J Yeung; Christopher P Cheng; Robert J Herfkens; Ronald L Dalman; Charles A Taylor
Journal:  Ann Biomed Eng       Date:  2010-11-20       Impact factor: 3.934

8.  STIM1 and STIM2 are located in the acidic Ca2+ stores and associates with Orai1 upon depletion of the acidic stores in human platelets.

Authors:  Hanene Zbidi; Isaac Jardin; Geoffrey E Woodard; Jose J Lopez; Alejandro Berna-Erro; Ginés M Salido; Juan A Rosado
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

9.  A MATHEMATICAL MODEL OF PLATELET AGGREGATION IN AN EXTRAVASCULAR INJURY UNDER FLOW.

Authors:  Kathryn G Link; Matthew G Sorrells; Nicholas A Danes; Keith B Neeves; Karin Leiderman; Aaron L Fogelson
Journal:  Multiscale Model Simul       Date:  2020-11-18       Impact factor: 1.930

10.  Steady flow visualization in a rigid model of the aortic bifurcation: application to atherosclerosis.

Authors:  Q M Ramadan; O Hamid; K O Lim
Journal:  J Biol Phys       Date:  2001-03       Impact factor: 1.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.